Morgan, Lewis & Bockius

Morgan, Lewis & Bockius LLP is a prominent global law firm, headquartered in Philadelphia, Pennsylvania, with over 30 offices spanning North America, Europe, Asia, and the Middle East. As a BigLaw firm, it is recognized among the top in the legal industry, ranking #5 on The American Lawyer's A-List in 2023 and #37 on the Vault Law 100 for 2026. The firm boasts a team of over 2,200 lawyers and specialists globally, providing comprehensive legal services across major industries including technology, life sciences, and manufacturing.

The firm's intellectual property litigation practice specializes in a broad array of technology areas. Its experience encompasses complex matters in semiconductors, electronics, software, cloud computing, artificial intelligence, and telecommunications. Morgan Lewis also has significant expertise in life sciences, handling disputes for biotechnology, medical device, and pharmaceutical companies, including Hatch-Waxman and Biosimilar Price Competition and Innovation Act (BPCIA) cases. Additionally, the firm litigates patent disputes involving mechanical devices, consumer electronics, automotive, and other product manufacturing sectors. The firm actively represents both plaintiffs and defendants, with a slightly higher volume of defendant-side appearances in tracked cases, reflecting its commitment to defending operating companies while also asserting client IP rights.

Morgan Lewis has achieved notable outcomes in high-stakes patent and IP litigation. The firm secured a significant victory for Canon, resulting in a stay of two patent infringement cases pending inter partes review (IPR) proceedings. In the life sciences sector, the firm successfully represented Salix Pharmaceuticals, with the Federal Circuit upholding a decision that prevented a generic version of a key drug from entering the market until 2029. Furthermore, the firm achieved a decisive win for Hugel Inc. and Hugel America at the International Trade Commission (ITC) in a high-profile trade secret misappropriation case, which paved the way for Hugel's entry into the US market.

The firm maintains a robust post-grant practice before the US Patent and Trademark Office (USPTO). Morgan Lewis is particularly recognized for its strong Patent Trial and Appeal Board (PTAB) practice, with partners like Alexander B. Stein co-leading the firm's efforts and overseeing more than 80 America Invents Act (AIA) trial proceedings. The team frequently represents both patent owners and petitioners in IPR proceedings, securing favorable patent validity decisions for clients across diverse industries, including medical devices, healthcare, and automotive accessories. Key partners in the firm's IP litigation practice include Ali S. Razai, Alexander B. Stein, Benjamin J. Everton, and Jason C. White, who regularly serve as lead counsel in complex disputes across various forums.